{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:04:09Z","timestamp":1790805849571,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1023\/a:1011934011690","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T06:29:09Z","timestamp":1040624949000},"page":"583-591","source":"Crossref","is-referenced-by-count":54,"title":["Pulmonary Bioavailability of a Phosphorothioate Oligonucleotide (CGP 64128A): Comparison with Other Delivery Routes"],"prefix":"10.1007","volume":"15","author":[{"given":"P. L.","family":"Nicklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Giddings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. L.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. G.","family":"Hastewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"303863_CR1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","volume":"75","author":"P. C. Zamecnik","year":"1978","unstructured":"P. C. Zamecnik and M. L. Stevenson, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA, 75:280\u2013284 (1978).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303863_CR2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-4781(90)90031-V","volume":"1049","author":"C. Helene","year":"1990","unstructured":"C. Helene and J. J. Toulme. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim. Biophys. Acta\n1049:99\u2013125 (1990).","journal-title":"Biochim. Biophys. Acta"},{"key":"303863_CR3","volume-title":"Therapeutic Applications of Oligonucleotides","author":"S. T. Crooke","year":"1995","unstructured":"S. T. Crooke Therapeutic Applications of Oligonucleotides. R. G. Landes Co., Austin, TX (1995)."},{"key":"303863_CR4","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1073\/pnas.90.21.9901","volume":"90","author":"K. A. Higgins","year":"1993","unstructured":"K. A. Higgins, J. R. Perez, T. A. Coleman, K. Dorshkind, W. A. McComas, U. M. Sarmiento, C. A. Rosen, and R. Narayanan. Antisense inhibition of the p65 subunit of NF-KB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA, 90:9901\u20139905 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303863_CR5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nm0696-668","volume":"2","author":"B. P. Monia","year":"1996","unstructured":"B. P. Monia, J. F. Johnston, T. Geiger, M. Mueller, and D. Fabbro, Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against c-raf kinase. Nature Medicine\n2:668\u2013675 (1996).","journal-title":"Nature Medicine"},{"key":"303863_CR6","first-page":"3499","volume":"56","author":"N. M. Dean","year":"1996","unstructured":"N. M. Dean, R. McKay, L. Miraglia, R. Howard, S. Cooper, J. Giddings, P. L. Nicklin, L. Miester, R. Ziel, T. Geiger, M. M\u00fcller, and D. Fabbro. Inhibition of human tumor cell lines in nude mice by a antisense inhibitor of PKC-\u03b1 expression. Cancer Res.\n56:3499\u20133507 (1996).","journal-title":"Cancer Res."},{"key":"303863_CR7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0167-7799(92)90203-8","volume":"10","author":"S. Agrawal","year":"1992","unstructured":"S. Agrawal, Antisense oligonucleotides as antiviral agents. Trends Biotechnol. Sci.\n10:152\u2013157 (1992).","journal-title":"Trends Biotechnol. Sci."},{"key":"303863_CR8","volume-title":"Handbook of Experimental Pharmacology","author":"P. L. Nicklin","year":"1998","unstructured":"P. L. Nicklin, S. J. Craig, and J. Phillips. Pharmacokinetics of phosphorothioates in animals. Antisense Research and Applications, Stanley T. Crooke (Ed.), Handbook of Experimental Pharmacology, Springer-Verlag, Heidelberg. 131: in press (1998)."},{"key":"303863_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/ard.1994.4.201","volume":"4","author":"W. M. Galbraith","year":"1994","unstructured":"W. M. Galbraith, W. C. Hobson, P. C. Giclas, P. J. Schechter, and S. Agrawal. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res. Dev.\n4:201\u2013206 (1994).","journal-title":"Antisense Res. Dev."},{"key":"303863_CR10","volume-title":"Handbook of Experimental Pharmacology","author":"A. A. Levin","year":"1998","unstructured":"A. A. Levin, D. K. Monteith, J. M. Leeds, P. L. Nicklin, R. S. Geary, M. Butler, M. V. Templin, and S. Henry. Toxicity of oligodeoxynucleotide therapeutic agents. Antisense Research and Applications, Stanley T. Crooke (Ed.), Handbook of Experimental Pharmacology, Springer-Verlag, Heidelberg. 131: in press (1998)."},{"key":"303863_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0169-409X(92)90002-8","volume":"8","author":"J. S. Patton","year":"1992","unstructured":"J. S. Patton and R. M. Platz. Pulmonary delivery of peptides and proteins for systemic action. Adv. Drug Delivery Rev.\n8:176\u2013196 (1992).","journal-title":"Adv. Drug Delivery Rev."},{"key":"303863_CR12","first-page":"31","volume-title":"Respiratory Drug Delivery","author":"M. Mackay","year":"1994","unstructured":"M. Mackay, J. A. Phillips, A. Steward, and J. G. Hastewell. Pulmonary absorption of therapeutic proteins and peptides, Respiratory Drug Delivery IV, pp 31\u201337. Eds. P. R. Byron, R. N. Dalby and S. J. Farr. Interpharm Press, IL 60089, USA (1994)."},{"key":"303863_CR13","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1093\/nar\/21.16.3737","volume":"21","author":"M. J. Graham","year":"1993","unstructured":"M. J. Graham, S. M. Freier, R. M. Crooke, D. J. Ecker, R. N. Maslova, and E. A. Lesnik. Tritium labeling of antisense oligonucleotides by exchange with tritiated water. Nucleic Acids Res.\n21:3737\u20133743 (1993).","journal-title":"Nucleic Acids Res."},{"key":"303863_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/abio.1996.0088","volume":"235","author":"J. M. Leeds","year":"1996","unstructured":"J. M. Leeds, M. J. Graham, L. Truong, and L. L. Cummins. Quantification of phosphorothioate oligonucleotides in human plasma. Anal. Biochem.\n235:36\u201343 (1996).","journal-title":"Anal. Biochem."},{"key":"303863_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-3565(25)12951-0","volume":"277","author":"S. T. Crooke","year":"1996","unstructured":"S. T. Crooke, M. J. Graham, J. E. Zuckerman, D. Brooks, B. S. Conklin, L. L. Cummins, M. J. Greig, D. Kornburst, M. Manoharan, H. Sasmor, T. Schleich, K. L. Tivel, and R. Griffey. Pharmacokinetic properties of several oligonucleotide analogs in mice. J. Pharm. Exp. Ther.\n277:923\u2013937 (1996).","journal-title":"J. Pharm. Exp. Ther."},{"key":"303863_CR16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0006-2952(97)00190-1","volume":"54","author":"J. A. Phillips","year":"1997","unstructured":"J. A. Phillips, S. J. Craig, D. Bayley, R. A. Christian, R. Geary, and P. L. Nicklin. Pharmacokinetics, metabolism and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846a) after intravenous and subcutaneous administration. Biochem. Pharmacol.\n54:657\u2013668 (1997).","journal-title":"Biochem. Pharmacol."},{"key":"303863_CR17","doi-asserted-by":"crossref","first-page":"15481","DOI":"10.1073\/pnas.93.26.15481","volume":"93","author":"B. P. Monia","year":"1996","unstructured":"B. P. Monia, H. Sasmor, J. F. Johnston, S. M. Freier, E. A. Lesnik, M. Muller, T. Geiger, K.-H. Altmann, H. Moser, D. Fabbro. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo. Proc. Natl. Acad. Sci. USA\n93:15481\u201315484 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303863_CR18","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1073\/pnas.88.17.7595","volume":"88","author":"S. Agrawal","year":"1991","unstructured":"S. Agrawal, J. Temsamani, and J. Y. Tang. Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. USA. 88:7595\u20137599 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303863_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/bdd.2510130308","volume":"13","author":"G. Goodarzi","year":"1992","unstructured":"G. Goodarzi, M. Watabe, and K. Watabe. Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice. Biopharm. Drug. Dispos.\n13:221\u2013227 (1992).","journal-title":"Biopharm. Drug. Dispos."},{"key":"303863_CR20","first-page":"531","volume":"6","author":"P. Iversen","year":"1991","unstructured":"P. Iversen. In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue. Anti-Cancer Drug Design. 6:531\u2013538 (1991).","journal-title":"Anti-Cancer Drug Design"},{"key":"303863_CR21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0022-3565(25)39459-0","volume":"267","author":"P. A. Cossum","year":"1993","unstructured":"P. A. Cossum, H., Sasmor, D. Dellinger, L. Truong, L. Cummins, S. R. Owens, P. M. Markham, J. P. Shea, and S. T. Crooke. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J. Pharm. Exp. Ther.\n267:1181\u20131190 (1993).","journal-title":"J. Pharm. Exp. Ther."},{"key":"303863_CR22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0026-895X(25)10208-3","volume":"45","author":"H. Sands","year":"1994","unstructured":"H. Sands, L. J. Gorey-Feret, A. J. Cocuzza, F. W. Hobbs, D. Chidester, and G. L. Trainor. Biodistribution and metabolism of internally H-labeled oligonucleotides. 1. Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol.\n45:932\u2013943 (1994).","journal-title":"Mol. Pharmacol."},{"key":"303863_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-199528010-00002","volume":"28","author":"S. Agrawal","year":"1995","unstructured":"S. Agrawal, J. Temsamani, W. Galbraith, and J. Tang. Pharmacokinetics of antisense oligonucleotides. Clin. Pharmacokinet.\n28:7\u201316, (1995).","journal-title":"Clin. Pharmacokinet."},{"key":"303863_CR24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0006-2952(95)00010-W","volume":"49","author":"R. Zhang","year":"1995","unstructured":"R. Zhang, R. B. Diasio, Z. Lu, T. Liu, Z. Jiang, W. M. Galbraith, and S. Agrawal. Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM-91) developed as a therapeautic agent for human immunodeficiency virus type-1. Biochem. Pharmacol.\n49:929\u2013939, (1995).","journal-title":"Biochem. Pharmacol."},{"key":"303863_CR25","first-page":"717","volume":"149","author":"A. Rifai","year":"1996","unstructured":"A. Rifai, W. Brysch, K. Fadden, J. Clark, and K.-H. Schlingensiepen. Clearance kinetics, biodistribution and organ saturability of phosphorothioate oligodeoxynucleotides in mice. Am. J. Pathol.\n149: 717\u2013725, (1996).","journal-title":"Am. J. Pathol."},{"key":"303863_CR26","first-page":"323","volume":"47","author":"M. Pinto","year":"1983","unstructured":"M. Pinto, S. Robine-Leon, M. D. Appay, M. Kedinger, N. Triadou, E. Dussalux, B. Lacroix, S. Assman, P. Haffen, J. Fogh, and A. Zweibaum. Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell\n47:323\u2013330 (1983).","journal-title":"Biol. Cell"},{"key":"303863_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-5173(82)90023-0","volume":"83","author":"P. L. Nicklin","year":"1992","unstructured":"P. L. Nicklin, W. J. Irwin, I. F. Hassan, I. Williamson, and M., Mackay. Permeable support type influences the transport of compounds across Caco-2 cells. Int. J. Pharm.\n83: 197\u2013209 (1992).","journal-title":"Int. J. Pharm."},{"key":"303863_CR28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0167-4889(95)00118-C","volume":"1269","author":"P. L. Nicklin","year":"1995","unstructured":"P. L. Nicklin, W. J. Irwin, I. F. Hassan, M. Mackay, and H. B. F. Dixon. The transport of acidic amino acids and their analogues across monolayers of human intestinal absorptive (Caco-2) cells in vitro. Biochim. et Biophys. Acta\n1269:176\u2013186 (1995).","journal-title":"Biochim. et Biophys. Acta"},{"key":"303863_CR29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1023\/A:1016002606705","volume":"13","author":"G. F. Beck","year":"1996","unstructured":"G. F. Beck, W. J. Irwin, P. L. Nicklin, and S. Akhtar. Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial cells. Pharm. Res.\n13:1028\u20131037 (1996).","journal-title":"Pharm. Res."},{"key":"303863_CR30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","volume":"175","author":"P. Artursson","year":"1991","unstructured":"P. Artursson and J. Karlsson. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commn.\n175:880\u2013885 (1991).","journal-title":"Biochem. Biophys. Res. Commn."},{"key":"303863_CR31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0006-2952(95)00160-2","volume":"50","author":"S. Agrawal","year":"1995","unstructured":"S. Agrawal, X. Zhang, Z. Lu, H., Zhao, J. M. Tamburin, J. Yan, H. Cai, R. B. Diasio, I. Habus, Z., Jiang, R. P. Iyer, D. Yu, and R. Zhang. Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration. Biochem. Pharmacol.\n50:571\u2013576 (1995).","journal-title":"Biochem. Pharmacol."},{"key":"303863_CR32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0006-2952(95)00159-W","volume":"50","author":"R. Zhang","year":"1995","unstructured":"R. Zhang, Z. Lu, H., Zhao, X. Zhang, R. B. Diasio, I. Habus, Z. Jiang, R. P. Iyer, D. Yu, and S. Agrawal. In vivo stability, disposition and metabolism of a \u201chybrid\u201d oligonucleotide phosphorothioate in rats. Biochem. Pharmacol.\n50:545\u201356 (1995).","journal-title":"Biochem. Pharmacol."},{"key":"303863_CR33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/385721a0","volume":"385","author":"J. W. Nyce","year":"1997","unstructured":"J. W. Nyce, and W. J. Metzger. DNA antisense therapy for asthma in an animal model. Nature\n385:721\u2013725 (1997).","journal-title":"Nature"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011934011690.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011934011690\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011934011690.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:47:11Z","timestamp":1754034431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011934011690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["303863"],"URL":"https:\/\/doi.org\/10.1023\/a:1011934011690","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}